BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10849589)

  • 1. Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity.
    Evans D; Mann WA; de Heer J; Michel U; Wendt D; Kortner B; Wolf A; Beisiegel U
    Int J Obes Relat Metab Disord; 2000 May; 24(5):647-51. PubMed ID: 10849589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.
    Evans D; de Heer J; Hagemann C; Wendt D; Wolf A; Beisiegel U; Mann WA
    Exp Clin Endocrinol Diabetes; 2001; 109(3):151-4. PubMed ID: 11409297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.
    Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Lebel P; Dallongeville J; Deeb S; Auwerx J; Amouyel P
    Hum Mol Genet; 1998 Mar; 7(3):435-40. PubMed ID: 9467001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
    Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel polymorphism of the human ob gene promoter in lean and morbidly obese subjects.
    Oksanen L; Kainulainen K; Heiman M; Mustajoki P; Kauppinen-Mäkelin R; Kontula K
    Int J Obes Relat Metab Disord; 1997 Jun; 21(6):489-94. PubMed ID: 9192233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.
    Evans D; Aberle J; Wendt D; Wolf A; Beisiegel U; Mann WA
    J Mol Med (Berl); 2001 May; 79(4):198-204. PubMed ID: 11409711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the peroxisome proliferator activated receptor gamma (PPARgamma) gene in HAIRAN syndrome with obesity.
    Globerman H; Zauberman Y; Makarov T; Beamer BA; Yen CJ; Shuldiner AR; Harel C; Karnieli E
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):479-85. PubMed ID: 10762291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inconsistent effects of the proline12 --> alanine variant of the peroxisome proliferator-activated receptor-gamma2 gene on body mass index in children and adolescent girls.
    Witchel SF; White C; Siegel ME; Aston CE
    Fertil Steril; 2001 Oct; 76(4):741-7. PubMed ID: 11591408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between polymorphisms in candidate genes and morbid obesity.
    Evans D; Wolf AM; Nellessen U; Ahle S; Kortner B; Kuhlmann HW; Beisiegel U
    Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S19-21. PubMed ID: 11466580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population.
    Meirhaeghe A; Fajas L; Gouilleux F; Cottel D; Helbecque N; Auwerx J; Amouyel P
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):289-94. PubMed ID: 12588773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.
    Valve R; Sivenius K; Miettinen R; Pihlajamäki J; Rissanen A; Deeb SS; Auwerx J; Uusitupa M; Laakso M
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3708-12. PubMed ID: 10523018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU
    Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with preeclampsia.
    Laasanen J; Heinonen S; Hiltunen M; Mannermaa A; Laakso M
    Early Hum Dev; 2002 Oct; 69(1-2):77-82. PubMed ID: 12324185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors.
    Krempler F; Breban D; Oberkofler H; Esterbauer H; Hell E; Paulweber B; Patsch W
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):443-9. PubMed ID: 10669642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases.
    Smith WM; Zhou XP; Kurose K; Gao X; Latif F; Kroll T; Sugano K; Cannistra SA; Clinton SK; Maher ER; Prior TW; Eng C
    Hum Genet; 2001 Aug; 109(2):146-51. PubMed ID: 11511919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Iovine C; Masulli M; Colantuoni V; Riccardi G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):481-6. PubMed ID: 12354130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PPARgamma in high-fat diet-induced obesity and insulin resistance.
    Kadowaki T; Hara K; Kubota N; Tobe K; Terauchi Y; Yamauchi T; Eto K; Kadowaki H; Noda M; Hagura R; Akanuma Y
    J Diabetes Complications; 2002; 16(1):41-5. PubMed ID: 11872365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population.
    Zhou XP; Smith WM; Gimm O; Mueller E; Gao X; Sarraf P; Prior TW; Plass C; von Deimling A; Black PM; Yates AJ; Eng C
    J Med Genet; 2000 Jun; 37(6):410-4. PubMed ID: 10851250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes.
    Clement K; Hercberg S; Passinge B; Galan P; Varroud-Vial M; Shuldiner AR; Beamer BA; Charpentier G; Guy-Grand B; Froguel P; Vaisse C
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):391-3. PubMed ID: 10757637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.